Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Lang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Scientific Reports|September 11, 2020
Low brain endocannabinoids associated with persistent non-goal directed nighttime hyperactivity after traumatic brain injury in miceAlexandra Vogel, Annett Wilken-Schmitz, Regina Hummel, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 3, 2023
Isolation of Lymphocytes from Human Skin and Murine Tissues: A Rapid and Epitope-Preserving ApproachAlexandra Polakova, Christoph Hudemann, Felix Wiemers, et al.
Mabs|December 15, 2022
Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reactionFabian Bickel, François Griaud, Wolfram Kern, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Scientific Reports|September 11, 2020
Low brain endocannabinoids associated with persistent non-goal directed nighttime hyperactivity after traumatic brain injury in miceAlexandra Vogel, Annett Wilken-Schmitz, Regina Hummel, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 3, 2023
Isolation of Lymphocytes from Human Skin and Murine Tissues: A Rapid and Epitope-Preserving ApproachAlexandra Polakova, Christoph Hudemann, Felix Wiemers, et al.
Mabs|December 15, 2022
Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reactionFabian Bickel, François Griaud, Wolfram Kern, et al.
Pageof 2